American Vanguard Corporation (AVD) Upgraded to Buy by Zacks Investment Research

Zacks Investment Research upgraded shares of American Vanguard Corporation (NYSE:AVD) from a hold rating to a buy rating in a report published on Friday. They currently have $23.00 price target on the basic materials company’s stock.

According to Zacks, “AMERICAN VANGUARD CORP. is a holding company, which through its subsidiaries, is engaged in the manufacturer and formulation of chemicals for crops, human and animal health protection. These chemicals which include insecticides, fungicides, molluscicides, growth regulatorsain, and soil fumigants, are marketed in liquid, powder, and granular forms. “

A number of other research firms also recently weighed in on AVD. Roth Capital set a $22.00 price target on shares of American Vanguard Corporation and gave the stock a buy rating in a research report on Wednesday, August 23rd. BidaskClub downgraded shares of American Vanguard Corporation from a sell rating to a strong sell rating in a research report on Friday, August 18th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the stock. American Vanguard Corporation currently has an average rating of Buy and a consensus price target of $20.67.

American Vanguard Corporation (NYSE:AVD) traded up 0.97% on Friday, reaching $20.75. 290,300 shares of the company’s stock traded hands. American Vanguard Corporation has a 52 week low of $14.20 and a 52 week high of $21.03. The firm has a market capitalization of $618.00 million, a P/E ratio of 42.35 and a beta of 1.29. The stock has a 50-day moving average of $20.02 and a 200 day moving average of $17.78.

American Vanguard Corporation (NYSE:AVD) last posted its quarterly earnings data on Monday, July 31st. The basic materials company reported $0.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.14 by $0.01. The company had revenue of $77.90 million for the quarter, compared to analyst estimates of $77.71 million. American Vanguard Corporation had a net margin of 4.56% and a return on equity of 5.10%. The business’s quarterly revenue was up 7.2% on a year-over-year basis. During the same quarter last year, the firm posted $0.11 earnings per share. On average, equities analysts expect that American Vanguard Corporation will post $0.63 EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This piece of content was originally published by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this piece of content on another publication, it was illegally copied and republished in violation of US and international copyright laws. The original version of this piece of content can be read at https://stocknewstimes.com/2017/09/16/american-vanguard-corporation-avd-upgraded-to-buy-by-zacks-investment-research.html.

In other news, insider David` T. Johnson sold 6,000 shares of the firm’s stock in a transaction that occurred on Monday, July 17th. The shares were sold at an average price of $19.00, for a total transaction of $114,000.00. Following the completion of the sale, the insider now owns 35,040 shares of the company’s stock, valued at $665,760. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 4.70% of the stock is currently owned by company insiders.

Several hedge funds have recently added to or reduced their stakes in the company. Walthausen & Co. LLC grew its position in shares of American Vanguard Corporation by 57.7% during the second quarter. Walthausen & Co. LLC now owns 701,722 shares of the basic materials company’s stock worth $12,105,000 after buying an additional 256,637 shares in the last quarter. The Manufacturers Life Insurance Company grew its position in shares of American Vanguard Corporation by 4.0% during the second quarter. The Manufacturers Life Insurance Company now owns 23,442 shares of the basic materials company’s stock worth $404,000 after buying an additional 895 shares in the last quarter. BlueCrest Capital Management Ltd grew its position in shares of American Vanguard Corporation by 150.0% during the second quarter. BlueCrest Capital Management Ltd now owns 50,000 shares of the basic materials company’s stock worth $863,000 after buying an additional 30,000 shares in the last quarter. State Street Corp grew its position in shares of American Vanguard Corporation by 4.2% during the second quarter. State Street Corp now owns 663,208 shares of the basic materials company’s stock worth $11,442,000 after buying an additional 26,587 shares in the last quarter. Finally, Voya Investment Management LLC grew its position in shares of American Vanguard Corporation by 12.6% during the second quarter. Voya Investment Management LLC now owns 15,495 shares of the basic materials company’s stock worth $267,000 after buying an additional 1,734 shares in the last quarter. 76.87% of the stock is owned by institutional investors and hedge funds.

American Vanguard Corporation Company Profile

American Vanguard Corporation operates as a holding company. The Company conducts its business through its subsidiaries, AMVAC Chemical Corporation (AMVAC), GemChem, Inc (GemChem), 2110 Davie Corporation (DAVIE), Quimica Amvac de Mexico SA de C.V. (AMVAC M), AMVAC Mexico Sociedad de Responsabilidad Limitada (AMVAC M Srl), AMVAC de Costa Rica Sociedad de Responsabilidad Limitada (AMVAC CR Srl), AMVAC Switzerland GmbH (AMVAC S), AMVAC do Brasil Representacoes Ltda (AMVAC B), AMVAC C.V.

Receive News & Ratings for American Vanguard Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Vanguard Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply